These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

452 related articles for article (PubMed ID: 22949815)

  • 1. Implication of tumor microenvironment in chemoresistance: tumor-associated stromal cells protect tumor cells from cell death.
    Castells M; Thibault B; Delord JP; Couderc B
    Int J Mol Sci; 2012; 13(8):9545-9571. PubMed ID: 22949815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Role of Tumor Microenvironment in Chemoresistance: To Survive, Keep Your Enemies Closer.
    Senthebane DA; Rowe A; Thomford NE; Shipanga H; Munro D; Mazeedi MAMA; Almazyadi HAM; Kallmeyer K; Dandara C; Pepper MS; Parker MI; Dzobo K
    Int J Mol Sci; 2017 Jul; 18(7):. PubMed ID: 28754000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncologic trogocytosis of an original stromal cells induces chemoresistance of ovarian tumours.
    Rafii A; Mirshahi P; Poupot M; Faussat AM; Simon A; Ducros E; Mery E; Couderc B; Lis R; Capdet J; Bergalet J; Querleu D; Dagonnet F; Fournié JJ; Marie JP; Pujade-Lauraine E; Favre G; Soria J; Mirshahi M
    PLoS One; 2008; 3(12):e3894. PubMed ID: 19079610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Taking a Full Snapshot of Cancer Biology: Deciphering the Tumor Microenvironment for Effective Cancer Therapy in the Oncology Clinic.
    Dzobo K
    OMICS; 2020 Apr; 24(4):175-179. PubMed ID: 32176591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor-associated stromal cells as key contributors to the tumor microenvironment.
    Bussard KM; Mutkus L; Stumpf K; Gomez-Manzano C; Marini FC
    Breast Cancer Res; 2016 Aug; 18(1):84. PubMed ID: 27515302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stromal Cells in the Tumor Microenvironment.
    Denton AE; Roberts EW; Fearon DT
    Adv Exp Med Biol; 2018; 1060():99-114. PubMed ID: 30155624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Breast tumor stroma: A driving force in the development of resistance to therapies.
    Majidinia M; Yousefi B
    Chem Biol Drug Des; 2017 Mar; 89(3):309-318. PubMed ID: 28042683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ovarian cancer microenvironment: implications for cancer dissemination and chemoresistance acquisition.
    Thibault B; Castells M; Delord JP; Couderc B
    Cancer Metastasis Rev; 2014 Mar; 33(1):17-39. PubMed ID: 24357056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutual concessions and compromises between stromal cells and cancer cells: driving tumor development and drug resistance.
    Nilendu P; Sarode SC; Jahagirdar D; Tandon I; Patil S; Sarode GS; Pal JK; Sharma NK
    Cell Oncol (Dordr); 2018 Aug; 41(4):353-367. PubMed ID: 30027403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recruited bone marrow derived cells, local stromal cells and IL-17 at the front line of resistance development to anti-VEGF targeted therapies.
    Darvishi B; Majidzadeh-A K; Ghadirian R; Mosayebzadeh M; Farahmand L
    Life Sci; 2019 Jan; 217():34-40. PubMed ID: 30472294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The critical role of the bone marrow stromal microenvironment for the development of drug screening platforms in leukemia.
    Panting RG; Kotecha RS; Cheung LC
    Exp Hematol; 2024 May; 133():104212. PubMed ID: 38552942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Curcumin suppresses crosstalk between colon cancer stem cells and stromal fibroblasts in the tumor microenvironment: potential role of EMT.
    Buhrmann C; Kraehe P; Lueders C; Shayan P; Goel A; Shakibaei M
    PLoS One; 2014; 9(9):e107514. PubMed ID: 25238234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent advances in understanding tumor stroma-mediated chemoresistance in breast cancer.
    Plava J; Cihova M; Burikova M; Matuskova M; Kucerova L; Miklikova S
    Mol Cancer; 2019 Mar; 18(1):67. PubMed ID: 30927930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor-Stromal Cell Communication: Small Vesicles Signal Big Changes.
    Wendler F; Stamp GW; Giamas G
    Trends Cancer; 2016 Jul; 2(7):326-329. PubMed ID: 28741534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploiting vulnerabilities of cancer by targeting nuclear receptors of stromal cells in tumor microenvironment.
    Cheng HS; Lee JXT; Wahli W; Tan NS
    Mol Cancer; 2019 Mar; 18(1):51. PubMed ID: 30925918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microenvironment acidity as a major determinant of tumor chemoresistance: Proton pump inhibitors (PPIs) as a novel therapeutic approach.
    Taylor S; Spugnini EP; Assaraf YG; Azzarito T; Rauch C; Fais S
    Drug Resist Updat; 2015 Nov; 23():69-78. PubMed ID: 26341193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Engineering stromal heterogeneity in cancer.
    Tang LJW; Zaseela A; Toh CCM; Adine C; Aydar AO; Iyer NG; Fong ELS
    Adv Drug Deliv Rev; 2021 Aug; 175():113817. PubMed ID: 34087326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stromal cells in tumor microenvironment and breast cancer.
    Mao Y; Keller ET; Garfield DH; Shen K; Wang J
    Cancer Metastasis Rev; 2013 Jun; 32(1-2):303-15. PubMed ID: 23114846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of the tumor microenvironment in mediating de novo resistance to drugs and physiological mediators of cell death.
    Hazlehurst LA; Landowski TH; Dalton WS
    Oncogene; 2003 Oct; 22(47):7396-402. PubMed ID: 14576847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stromal androgen receptor regulates the composition of the microenvironment to influence prostate cancer outcome.
    Leach DA; Need EF; Toivanen R; Trotta AP; Palethorpe HM; Tamblyn DJ; Kopsaftis T; England GM; Smith E; Drew PA; Pinnock CB; Lee P; Holst J; Risbridger GP; Chopra S; DeFranco DB; Taylor RA; Buchanan G
    Oncotarget; 2015 Jun; 6(18):16135-50. PubMed ID: 25965833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.